Brücke J, Tanew A, Ortel B, Hönigsmann H
Department of Dermatology I, University of Vienna, Austria.
Br J Dermatol. 1991 Apr;124(4):372-4. doi: 10.1111/j.1365-2133.1991.tb00601.x.
The action spectrum for the induction of phototoxic erythema by treatment with 8-methoxypsoralen (8-MOP) and UVA peaks at around 335 nm. Because earlier investigations reported peak phototoxic activity at 365 nm, we compared the antipsoriatic efficacy of 335 and 365 nm in an oral psoralen photochemotherapy (PUVA) regimen using a monochromator. PUVA with 335 nm was twice as effective as with 365 nm, with respect to both erythemogenicity and the cumulative dose required for clearing psoriasis. However, 335 and 365 nm were equally effective if delivered in equal erythema doses. It appears that in human skin the antipsoriatic activity of 8-MOP parallels its erythemogenicity.
用8-甲氧基补骨脂素(8-MOP)和紫外线A(UVA)治疗诱导光毒性红斑的作用光谱在335nm左右达到峰值。由于早期研究报告光毒性活性峰值在365nm,我们使用单色仪比较了在口服补骨脂素光化学疗法(PUVA)方案中335nm和365nm的抗银屑病疗效。就红斑形成能力和清除银屑病所需的累积剂量而言,335nm的PUVA疗效是365nm的两倍。然而,如果给予相同的红斑剂量,335nm和365nm的效果相同。看来在人体皮肤中,8-MOP的抗银屑病活性与其红斑形成能力相似。